India vs Sri Lanka: Measles-containing-vaccine second-dose (MCV2) immunization coverage
India
95.0%
in 2025
Sri Lanka
95.0%
in 2025
India rank
29th
Sri Lanka rank
29th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- India
- Sri Lanka
How they compare
India currently reports 95.0% against 95.0% in Sri Lanka, a difference of 0.0%.
Across all 26 years both countries report, Sri Lanka has been ahead every year.
India ranks 29th and Sri Lanka ranks 29th of 194 countries.
Sri Lanka has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | India | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 81.7% | 81.7% | Sri Lanka |
| 2010s | 56.5% | 99.0% | 42.5% | Sri Lanka |
| 2020s | 88.3% | 97.2% | 8.8% | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, India or Sri Lanka?
- India, at 95.0% against 95.0% in Sri Lanka as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between India and Sri Lanka?
- 0.0%, with India ahead.
- How many years of comparable data are there for India and Sri Lanka?
- 26 years are reported by both, from 2000 to 2025.
- How do India and Sri Lanka rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- India ranks 29th and Sri Lanka ranks 29th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.